Innovus Pharma Announces the Approval of its Product ProstaGorx in Canada for Benign Prostate Hyperplasia (“BPH”)
5:07 PM June 4, 2018ProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire – Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market:INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the approval by Health Canada of its product ProstaGorx as a Natural Health Product (NPN # 80085717) for
Read more